MedPath

Brain-to-Society Diagnostic for Prevention of Childhood Obesity and Chronic Disease

Conditions
Obesity
Registration Number
NCT03151694
Lead Sponsor
McGill University
Brief Summary

This multi-national program applies a breakthrough approach to childhood obesity called, Brain-to-Society (BtS) Diagnostic Approach. In Montreal, Canada and Palwal, India, the investigators will recruit two cohorts of 612 children (6 to 12 years; 306 boy/306 girls) where Whole-of-Society (WoS) transformations are taking place (industrialized societal context with peaking childhood obesity and where a broad governmental plan to promote healthy lifestyle has been adopted -Canada; developing societal context with increasing childhood obesity if replication of past pathways that have lead to double burden; India) are taking place along with World Health Assembly (WHA) resolution A63-12 for marketing of food to children. Individual-level BtS Diagnostic will examine the degree to which individual differences in genetics and biology and differences in the environmental exposures modulate the behavioral, body weight/fatness and nutritional risk over time in the context of WoS transformations. Societal-level BtS Diagnostic shall examine the influence of decisions in policy, investment, business and innovation made by different stakeholders (government, private sector, civil society in health and non-health society systems including agriculture, business and media practices) on the community.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1224
Inclusion Criteria
  • Sample population that are exposed to multi-level Whole-of-Society transformation (i.e., Quebec Governmental Action Plan (PAG) and World Health Assembly (WHA) resolution for Quebec sample; Intense Urbanization and Industrialization (IUI) and WHA resolution in India).
Exclusion Criteria
  • first cousin relations were excluded from the sample population.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Individual-level BtS Diagnostic 12 years

Genotyping and detection of the Taq1A allele in the dopamine-2 receptor (DRD2) gene.

Individual-level BtS Diagnostic 22 years

Genotyping and detection of the exon 3 7-repeat allele of the dopamine-4 receptor (DRD4) gene.

Secondary Outcome Measures
NameTimeMethod
Behavioral Assessment2 years

Assess behavior of each participant in relation to food choice

Nutritional Risk Assessment2 years

Assess nutrition intake for each participant.

Body Weight Assessment2 years

Assess body weight of each participant

Trial Locations

Locations (2)

The INCLEN Trust International

🇮🇳

New Delhi, India

McGill Centre for the Convergence of Health and Economics (MCCHE)

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath